US Patent Issued to Incyte on July 22 for "Aminopyrazine diol compounds as PI3K-y inhibitors" (Delaware, Pennsylvania Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,668, issued on July 22, was assigned to Incyte Corp. (Wilmington, Del.).

"Aminopyrazine diol compounds as PI3K-y inhibitors" was invented by Stacey Shepard (Wilmington, Del.), Andrew P. Combs (Kennett Square, Pa.), Nikoo Falahatpisheh (Wilmington, Del.) and Lixin Shao (Wilmington, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to compounds of Formula (I):or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-Gamma which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases."

The patent was filed on Feb. 1, 2024, under A...